| Insider | Title | Company | Date | Price | Return | Shares | Value |
|---|---|---|---|---|---|---|---|
| Hassan Fred | Non-Executive Director | PRECIGEN, INC. (PGEN) | 2023-08-14 | $1.75 | -45.2% | 570,345 | $998,104 |
| Hassan Fred | Non-Executive Director | BridgeBio Pharma, Inc. (BBIO) | 2021-12-29 | $14.17 | 121.0% | 19,300 | $273,390 |
| Return | Profit / (loss) | Cost | |||||
| Total | -9.5% | $-120,443 | $1,271,494 |